KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹844 Cr | ₹743 Cr | ₹650 Cr | ₹611 Cr | ₹439 Cr |
What is the latest Total Liabilities ratio of KOPRAN ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹844 Cr |
| Mar2024 | ₹743 Cr |
| Mar2023 | ₹650 Cr |
| Mar2022 | ₹611 Cr |
| Mar2021 | ₹439 Cr |
How is Total Liabilities of KOPRAN Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹844 Cr | 13.56 | |
| Mar2024 | ₹743 Cr | 14.40 | |
| Mar2023 | ₹650 Cr | 6.35 | |
| Mar2022 | ₹611 Cr | 39.03 | |
| Mar2021 | ₹439 Cr | - | |
Compare Total Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹751.3 Cr | 6.4% | 25.2% | -10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 6.4% |
25.2% |
-10.9% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses